NCT05546814

Brief Summary

The purpose of this project is to determine the direct impact of sodium supplementation in preterm infants and to see the overall improvement of their growth and health status. from this study will help us develop a better treatment for in the future.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
6

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Feb 2023

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 15, 2022

Completed
6 days until next milestone

First Posted

Study publicly available on registry

September 21, 2022

Completed
5 months until next milestone

Study Start

First participant enrolled

February 8, 2023

Completed
2.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 14, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 14, 2025

Completed
Last Updated

August 11, 2025

Status Verified

April 1, 2025

Enrollment Period

2.2 years

First QC Date

September 15, 2022

Last Update Submit

August 6, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Preterm infant weight gain

    To determine the relationship among sodium intake, bodily growth and the gut in preterm infants

    8 weeks

Secondary Outcomes (1)

  • Microbiome

    8 weeks

Study Arms (2)

Sodium algorithm

EXPERIMENTAL

Starting at 2 weeks of age, the sodium algorithm group will be started based on their sodium levels. This will be adjusted weekly based on weight gain and sodium levels.

Procedure: Sodium algorithm

Control

NO INTERVENTION

Subjects will be cared for by current protocols

Interventions

Infants will receive sodium and follow a sodium supplementation schedule or algorithm. This means that based on the sodium levels collected from the samples (stool and urine) they will receive an increase or maintain the same amount to help

Sodium algorithm

Eligibility Criteria

Age25 Weeks - 30 Weeks
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)

You may qualify if:

  • Birthweight \>500 grams and
  • Gestational age at least 25 0/7weeks but less than 30 weeks.
  • \<14 days of age at time of randomization

You may not qualify if:

  • Non-English speaking parents
  • Major congenital anomalies
  • grade underlying renal dysfunction (serum creatinine \> 1.0 mg/dL or increase of \>0.3 mg/DL between any two consecutive measurements)
  • any structural genitourinary criteria.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Children's wisconsin

Milwaukee, Wisconsin, 53226, United States

Location

MeSH Terms

Conditions

Premature Birth

Condition Hierarchy (Ancestors)

Obstetric Labor, PrematureObstetric Labor ComplicationsPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital Diseases

Study Officials

  • Jeffrey Segar, MD

    Medical College of Wisconsin

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: Two cohorts; experimental and control
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

September 15, 2022

First Posted

September 21, 2022

Study Start

February 8, 2023

Primary Completion

April 14, 2025

Study Completion

April 14, 2025

Last Updated

August 11, 2025

Record last verified: 2025-04

Data Sharing

IPD Sharing
Will not share

Locations